EDUCATIONAL EVENTS

Upcoming events

    • 16 Dec 2024
    • 06 Nov 2026
    • Online, USA Central time
    Register

    ICHS Members: Complimentary -
    Please log in first to register
    as a member
    .

    Early Career, Low/Middle Income Countries, Global Access: Complimentary - includes a one-year membership in ICHS.

    Non-members: $25USD - includes a one year ICHS membership.



    Exciting online session from ICHS offering education about the new advances in CMV management! This webinar provides dynamic, interactive content on the latest updates on CMV infections from updated guidelines to the utility of measuring CMV T Cell immunity to the burden of CMV post cellular therapy, based on needs assessments and questions from the attendees.

    Access this resource for a comprehensive scientific session with insights into cutting-edge research, innovative care practices, and updated guidelines with a diverse range of experts.

    • Learn from the co-chair of the ECIL guidelines for CMV about the latest changes made since the last update.
    • Understand the role of CMV T Cell Immunity in mitigating the risk of CMV infections in Allogeneic Cell Transplant recipients.
    • Learn about the latest updates on risk of CMV infections after cellular therapy and its impact on oncologic outcomes.

    Meet the Speakers:

    Rafael de la Cámara, MD 
    Faculty Member, Hematology
    Hospital de la Princesa
    Hospital Universitario De La Princesa
    Faculty Member
    Hospital de la Zarzuela
    Madrid, Spain

    Biography for Dr. de la Camara - click here.

    Joshua A. Hill, MD
    Associate Professor, Department of Medicine, Division of Allergy and Infectious Diseases
    University of Washington Medical Center
    Assistant Professor, Vaccine and Infectious Disease Division, Clinical Research Division
    Fred Hutchinson Cancer Center
    Seattle, Washington USA

    Biography for Dr. Hill - click here.

    Michelle K. Yong, MBBS, FRACP, MPH, PhD
    Infectious Diseases Physician
    University of Melbourne
    Peter MacCallum Cancer Centre
    Melbourne, Australia



    Biography for Dr. Yong - click here.

    • 29 Apr 2025
    • 06 Nov 2026
    • Online, USA
    Register

    An ICHS online educational session for the care of immunocompromised patients!

    ICHS Members: Complimentary
    (Log in first for this option.)

    Complimentary: Low/ middle income, early career and global access attendees.


    Non-members: $25USD -
    includes a one year ICHS membership. 




    Speakers and ORCID's are available on the education page.


    Supported by An Educational Grant From:



    Sponsor Support:




           


    Refunds must be requested within 48 hours in advance of the session. All refunds are subject to review and approval and will be issued after the event.

    • 28 May 2025
    • 06 Nov 2026
    • Online, USA
    Register

    ICHS Early Career Opportunity!  

    Free for ICHS Members!


    This dynamic ICHS online meeting was designed to advance Early Career education and career advancement opportunities.  
    The was an interactive collaboration session to engage with ICHS Council, global ambassadors, mentors and peers to exchange ideas, and help shape Early Career ICHS programs.

    If you are an early career member and need assistance with your ICHS membership, please contact us.

    • 29 May 2025
    • 06 Nov 2026
    • Online, USA
    Register

    ICHS Members: Complimentary (Log in first for this option.)

    Complimentary: Low/ middle income, early career and global access attendees.

    Non-members: $25USD - includes a one year ICHS membership.

    This informative session on measles is specifically tailored for healthcare professionals working with immunocompromised patients.

    The session delves into the unique challenges and risks that measles poses to immunocompromised individuals, including those undergoing treatments such as chemotherapy, organ transplants, living with chronic conditions, or taking medications that weaken the immune system.

    Explore the latest clinical features, epidemiology, and prevention strategies to effectively manage and mitigate the impact of measles in this vulnerable population.

    Attendees will gain valuable insights into best practices for vaccination, post-exposure prophylaxis, and infection control measures to ensure the safety and well-being of immunocompromised patients.

    Supported by An Educational Grant From:




    • 02 Jun 2025
    • 06 Nov 2026
    • Online, USA
    Register

    This webinar is in Spanish.

    Nueva oportunidad de seminario web educativo

    (Dengue in the Immunocompromised Host: When the Globalization Becomes a Reality.)

    Acompáñanos en esta sesión sobre los desafíos del diagnóstico y manejo del dengue en pacientes inmunocomprometidos.

    Webinars are offered as an on-demand resource following the session.





    ICHS Members: Complimentary (Log in first for this option.)

    Complimentary for Low/ middle income, early career and global access attendees.


    Non-members: $25USD - includes a one year ICHS membership. 


    Conversando con expertos.


    Session Details:

    Coordinación Dra Patricia Costantini

    Temas que se abordaran en una sesión interactiva

    El cambio climático y la transmisión de virus re-emergentes en la región de las Americas
    Dr Tomás Orduna

    Impacto del Dengue en el paciente con cancer y TCPH
    Dra Claudia Salgueira

    Dengue y las transfusiones: cual es la real trascendencia?
    Dr José Eduardo Levi

    Implicancia de un brote de dengue en una Unidad de IC en Brasil 
    Dra Marjorie Vieira Batista


    Moderator: Convener Patricia Costantini

    The climate change and the transmission of reemerging viruses in the Americas
    Dr Tomás Orduna

    Impact of Dengue in the patient with cancer and HSCT
    Dra Claudia Salgueira

    Arbovirus and Blood transfusions
    Dr José Eduardo Levi

    Experience of a unit of immunocompromised patients during the outbreak of Dengue in Brazil
    Dra Marjorie Vieira Batista


    Supported by An Educational Grant From:





    Refunds must be requested within 48 hours in advance of the session. All refunds are subject to review and approval and will be issued after the event.

    • 04 Jul 2025
    • 06 Nov 2026
    • Online, USA
    Register

    Free for ICHS members and most levels! 

    Free for Low/middle income, early career, global access attendees include a one-year membership

    Non-members: $25 USD - includes a one-year membership 

    Webinar on Donor-Derived Infections: A Case-Based Approach

    This interactive webinar will explore donor-derived infections in both solid organ transplantation and hematopoietic cell transplantation, offering dynamic content and expert insights.

    Join a panel of leading experts for an engaging session featuring polling questions, expert perspectives, and innovative care strategies to enhance decision-making in donor-derived infections.

    Agenda:

    Current Knowledge & Best Practices – A summary of existing data in solid organ and hemopoietic cell transplantation.

    Case-Based Discussions – Given the limited data, decisions are often made case by case. We will analyze real-world scenarios to discuss when to defer, when risks are acceptable, and how to respond when donor infections emerge post-transplant.

    Audience-Driven Q&A – Expanding the discussion with questions submitted in advance and live inquiries during the session.

    Objectives:

    • Review the current epidemiology and where to look for reliable data to rely on for our decision.
    • Identify how to make decisions through an interactive format.
    • Review where we have clear gaps, and unmet needs.
    • Discuss how we can improve knowledge in this field.


    Please take advantage of these offerings which will provide you with the opportunity for future educational opportunities throughout the year.


    If you need assistance with joining or renewing your membership, please contact us at the ICHS Office.


    • 11 Jul 2025
    • 30 Oct 2026
    • Online, USA
    Register

    New Educational On Demand Opportunity! 

    ICHS Members: Complimentary (Log in first for this option.)

    Complimentary for Low/ middle income, early career and global access attendees.


    Non-members: $25USD - includes a one year ICHS membership. 



    Click here for the webinar description and speaker Bios.



    Refunds must be requested within 48 hours in advance of the session. All refunds are subject to review and approval and will be issued after the event.

    • 20 Oct 2025
    • 5:30 AM
    • 20 Oct 2026
    • 7:00 AM
    • Online, USA
    Register


    ICHS Members: Complimentary (Log in first for this option.)

    Complimentary: Low/ middle income, early career and global access attendees.

    Non-members: $25USD - includes a one year ICHS membership.

    Please click here for the webinar program and speaker Bios.



    Take advantage of this on demand informative session specifically tailored for healthcare professionals working with immunocompromised patients.

    Supported by An Educational Grant From:



    All refund requests are subject to review and approval.

    • 17 Nov 2025
    • 10:00 AM
    • 05 Nov 2027
    • 11:30 AM
    • Online, USA
    Register



    Stay at the forefront of HSV care and improve patient outcomes.

    ICHS Members: Complimentary (Log in first for this option.) 

    Complimentary: Early career and global access attendees.

    Non-members: $25USD - includes a one year ICHS membership.

    Click here for the program and speaker Bios. 


    Advance your expertise in HSV in this webinar designed specifically for all healthcare providers in the immunocompromised field. Learn directly from leading experts to clarify complex clinical scenarios.

    The session included dynamic content from the advance needs assessment results, pre-webinar questions from registrant submissions, live polling, case discussions, and a panel Q&A session.

    Objectives:

    • This session will provide you with the latest knowledge on HSV-1 and HSV-2 infections
    • Learn about the burden of severe HSV infections in immunosuppressed patient
    • Review a clinical case of a complicated HSV infection
    • Understand the role and the potential indications of new agents under investigation Current and emerging antiviral therapies and management strategies

    Key Outcomes:

    • Gain updated practical knowledge on treating and managing HSV Improve diagnostic accuracy and patient counseling techniques      Understand HSV’s clinical impact, including ocular, neurological, and neonatal risk  Learn strategies to reduce viral transmission and improve patient outcomes

    Join us for an informative session specifically tailored for healthcare professionals working with immunocompromised patients.

    Supported by An Educational Grant From:


    All refund requests are subject to review and approval.

    • 08 Jun 2026
    • 10:00 AM
    • 26 May 2028
    • 11:30 AM
    • Online, USA
    Register

    Stay at the forefront of HSV care and improve patient outcomes.

    ICHS Members: Complimentary (Log in first for this option.) 

    Complimentary: Early career and global access attendees.

    Non-members: $25USD - includes a one year ICHS membership.

    Faculty Bios:

    Dr. Papanicolaou

    Dr. Shafat

    Dr. Chemaly


    • 16 Sep 2026
    • 8:00 AM - 9:00 AM
    • Online, Zoom
    Register


    ICHS Members: Complimentary (Log in first for this option.)

    Complimentary:  early career and global access attendees.

    Non-members: $25USD, includes a one year ICHS membership and access to all membership benefits.

    Click here to check the time for your location. 

    Join ICHS for this webinar where we will present a case-based approach to evaluating immunocompromised travelers returning from South America, the Middle East, and Asia, with syndromes such as fever, rash, skin lesions, etc, focusing on locally prevalent arbovirus infections, bacterial and parasitic infections.

    Participants will review region-specific and country-specific epidemiologic risks, differential diagnoses, practical approaches to diagnosis in non-endemic settings, treatment, and prevention.

    Emphasis will be placed on how clinical presentation, diagnosis, prevention, and management of these travel-related infections might differ in immunocompromised populations (SOT/HCT/B-cell depletion) compared with immunocompetent travelers.

    Learning Objectives

    • Differentiate the epidemiology, clinical manifestations, and diagnostic approach to key travel-related infections in immunocompromised travelers returning from South America, the Middle East, and Asia, with consideration of specific immunocompromised populations
    • Develop region-specific differential diagnoses for fever and common post-travel syndromes.
    • Apply evidence-based strategies for prevention, diagnostic evaluation, and management of travel-associated infections in immunocompromised.

    Join us for an informative session specifically tailored for healthcare professionals working with immunocompromised patients.


    Presenters (in alpha order)

    Maha Alamri, MBBS, MSCI: Dr. Maha Alamri is a Transplant Infectious Disease Consultant at King Faisal Specialist Hospital and Research Center (KFHRC), in Riyadh, Saudi Arabia.

    Gustavo Méndez, MD: Dr. Gustavo Méndez the is Head of the Department of Internal Medicine and staff physician of the Infectious Diseases Service of the Hospital Escuela de Agudos Dr. Ramón Madariaga de Posadas, Misiones, Argentina. He is a professor of Infectious Diseases at the Faculty of Medicine of the Catholic University of the Missions (UCAMI). He is a specialist in Infectious Diseases from the Faculty of Medicine of the University of Buenos Aires (UBA), Argentina.

    Siriorn Watcharananan, MD, FIDSA: Dr. Siriorn Watcharananan is an infectious disease specialist and Associate Professor of Medicine, Division of Infectious Disease, Department of Medicine at the Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

    Please contact admin@ichs.org if you need any assistance. 

    • 01 Oct 2026
    • 9:00 AM - 10:00 AM
    • Online, Zoom
    Register

    This webinar will be a case-based educational webinar that transitions naturally into discussion of current evidence and future implementation of HPIs.

    ICHS Members: Complimentary
    (Log in first for this option.)

    Complimentary:  early career and global access attendees.

    Non-members: $25USD - includes a one year ICHS membership.

    Click here to check the time for your location. 

    Join ICHS for an interactive, case-based webinar where real-world scenarios set the stage for a dynamic discussion on the latest evidence and the outlook of Helicase Primase Inhibitors (HPIs). This session will reflect the evolution of the field with the future introduction of HPIs, the available clinical evidence, and how these therapies may be integrated into future practice.

    Dr. Roy Chemaly will facilitate a moderated discussion with the presenters to provide attendees with both the scientific rationale and the clinical context for incorporating HPIs into future management strategies for Refractory HSV in immunocompromised patients.

    During the webinar we will:

    • Analyze compelling cases that mirror major challenges
    • Explore current research shaping best practices
    • Envision practical strategies for future implementation

    Webinar Agenda includes:

    • Case Presentation & Current Management – Dr. Joseph Sassine
    • Helicase-Primase Inhibitor Overview & Phase 2 Data – Dr. Camille Kotton
    • Phase 3 Clinical Evidence & Real-World Perspective - Dr. Zenia Papanicolaou
    • Moderated Discussion & Audience Q&A – Dr. Roy Chemaly

    Whether you are looking to sharpen your clinical reasoning or stay ahead of emerging trends, this session offers evidence driven insight and actionable takeaways.

    Reserve your spot today and be part of the conversation shaping tomorrow’s
    HPI landscape.

    Faculty (click here for Faculty Bios)

    Dr. Roy F. Chemaly
    UT MD Anderson Cancer Center
     

    Dr. Camille Kotton
    M
    assachusetts General Hospital
    Harvard Medical School

    Dr. Genovefa (Zenia) Papanicolaou
    Memorial Sloan-Kettering Cancer Center
    Weill Cornell Medical College

    Dr. Joseph Sassine
    OU College of Medicine 
    University of Oklahoma


International Immunocompromised Host Society

admin@ichs.org | +1 412-344-1414
Powered by Wild Apricot Membership Software